Evidence map›Paper›PMID 29159980›Full record

ArticleJournal of cellular and molecular medicine2018

Role of PI3K in myocardial ischaemic preconditioning: mapping pro-survival cascades at the trigger phase and at reperfusion.

Xavier Rossello, Jaime A Riquelme, Sean M Davidson, Derek M Yellon

Open access · goldAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. The role and mechanism of cinnamaldehyde in cancer.Journal of food and drug analysis · 2024
    Review
  7. Article
  8. Article
  9. Review
  10. Observational
  11. Review
  12. Article
  13. Article
  14. Review
  15. Inhibition of PI3K/mTOR/KArchives of pharmacal research · 2021
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Xavier RosselloThe Hatter Cardiovascular Institute, University College London, London, UK.
Jaime A RiquelmeThe Hatter Cardiovascular Institute, University College London, London, UK.
Sean M DavidsonThe Hatter Cardiovascular Institute, University College London, London, UK.ORCID 0000-0001-5182-4980
Derek M YellonThe Hatter Cardiovascular Institute, University College London, London, UK.ORCID 0000-0001-7791-9320
University College London · GBAdvanced Center for Chronic Diseases · CL

Funding

British Heart Foundation PG/10/005/28175British Heart Foundation PG/16/85/32471British Heart Foundation PG/18/44/33790
6 · The paper itself

Abstract

The Reperfusion Injury Salvage Kinase (RISK) pathway is considered the main pro-survival kinase cascade mediating the ischaemic preconditioning (IPC) cardioprotective effect. To assess the role of PI3K-Akt, its negative regulator PTEN and other pro-survival proteins such as ERK and STAT3 in the context of IPC, C57BL/6 mouse hearts were retrogradely perfused in a Langendorff system and subjected to 4 cycles of 5 min. ischaemia and 5 min. reperfusion prior to 35 min. of global ischaemia and 120 min. of reperfusion. Wortmannin, a PI3K inhibitor, was administered either at the stabilization period or during reperfusion. Infarct size was assessed using triphenyl tetrazolium staining, and phosphorylation levels of Akt, PTEN, ERK, GSK3β and STAT3 were evaluated using Western blot analyses. IPC reduced infarct size in hearts subjected to lethal ischaemia and reperfusion, but this effect was lost in the presence of Wortmannin, whether it was present only during preconditioning or only during early reperfusion. IPC increased the levels of Akt phosphorylation during both phases and this effect was fully abrogated by PI3K, whilst its downstream GSK3β was phosphorylated only during the trigger phase after IPC. Both PTEN and STAT3 were phosphorylated during both phases after IPC, but this was PI3K independent. IPC increases ERK phosphorylation during both phases, being only PI3K-dependent during the IPC phase. In conclusion, PI3K-Akt plays a major role in IPC-induced cardioprotection. However, PTEN, ERK and STAT3 are also phosphorylated by IPC through a PI3K-independent pathway, suggesting that cardioprotection is mediated through more than one cell signalling cascade.

Indexed as

Ischemic Preconditioning, MyocardialAnimalsEnzyme ActivationExtracellular Signal-Regulated MAP KinasesGlycogen Synthase Kinase 3 betaMaleMice, Inbred C57BLMyocardial Reperfusion InjuryPhosphatidylinositol 3-KinasesPhosphorylationProtein Kinase InhibitorsProto-Oncogene Proteins c-aktPTEN PhosphohydrolaseSignal TransductionSTAT3 Transcription FactorSurvival AnalysisExtracellular Signal-Regulated MAP KinasesGlycogen Synthase Kinase 3 betaPhosphatidylinositol 3-KinasesProtein Kinase InhibitorsProto-Oncogene Proteins c-aktPTEN PhosphohydrolaseSTAT3 Transcription Factorcardioprotectionischaemia/reperfusion injuryischaemic preconditioningRISK pathwaySAFE pathway

Identifiers

PMID29159980
PMCPMC5783840
OpenAlexW2768690329

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.